J&J To Pay Up To $15 Mil. To Settle Remaining Propulsid Cases
This article was originally published in The Pink Sheet Daily
Executive Summary
When combined with an earlier settlement agreement, J&J’s total liability for the bulk of the claims will be capped at $105 mil.
You may also be interested in...
P&G To Develop Phase II GERD Drug Under Agreement With ARYx Therapeutics
P&G will make a $25 mil. up-front payment to ARYx Therapeutics to develop and commercialize the serotonin type 4 agonist.
P&G To Develop Phase II GERD Drug Under Agreement With ARYx Therapeutics
P&G will make a $25 mil. up-front payment to ARYx Therapeutics to develop and commercialize the serotonin type 4 agonist.
J&J Agrees To Propulsid Settlement
A Johnson & Johnson Propulsid litigation settlement will become effective once 85% of the death claims agree to its terms